Skip to main content

Newsroom

Press Releases

February 22, 2018
Reaffirms full year 2018 forecast and 2020 goals Revises 1Q 2018 forecast GAITHERSBURG, Md., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) reported financial results for the quarter and twelve months ended December 31, 2017. 2017 FINANCIAL HIGHLIGHTS (in mil...

 


Maryland BioHealth Success Story 

Media
Lynn R. Kieffer
kiefferl@ebsi.com 
TEL 240-631-3391 

Investors
Robert Burrows 
burrowsr@ebsi.com 
TEL 240-631-3280